275P Clinical and molecular impact of neoadjuvant chemotherapy (NACT) or endocrine therapy (NET) on hormone receptor positive (HR+)/HER2-negative (-) breast cancer (BC)
| Autor: | Schettini, F., Brasó-Maristany, F., Pascual, T., Galván, P., Conte, B., Ghiglione, L., Falato, C., Martínez-Sáez, O., Chic, N., Rodriguez, A.B., Torres, E. Sanfeliu, Gonzalez-Farre, B., Losada, M.J. Vidal, Adamo, B., Cebrecos, I., Mension, E., Oses, G., Mollá, M., Munoz, M., Prat, A. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S294-S294 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|